Roy Malkin, the former CEO of Minntech Corp. who was seriously injured last spring in a plane crash, has been back with the company on a limited basis since September, according to a regulatory filing.
Malkin’s private single-jet plane crashed in early June in Crystal, Minn., as the plane was attempting to take off.
He returned to the Plymouth, Minn.-based kidney dialysis device company in September, according to the filing, and inked a two-year contract to serve as a senior advisor to Minntech and the CEO of its corporate parent, Cantel Medical (NYSE:CMN).
Malkin will advise executive vice president Paul Helms, who’s has been leading the company since the accident. He’ll be working 30-hour weeks in 2012 for a base salary of $430,000 and no more than 10 hours a week for $100,000 a year in 2013. If he retires before then, Malkin’s options and restricted stock will vest in full.
Upadhyay was promoted from VP of finance for BD’s international division, where he’d served since August 2010. He’s a finance veteran with a pedigree including AstraZeneca (NYSE:AZN) and Johnson & Johnson (NYSE:JNJ) subsidiary Centocor.
Upadhyay, 42, succeeded William Tozzi, "who has assumed another position within BD," according to a regulatory filing. Read more
Artimplant names new U.S. president, marketing chief
Swedish orthopedic implant maker Artimplant (STO:ARTIB) named Jimmy Jones to be its U.S. president and head of marketing.
The company also shuffled its sales deck, bringing on "two persons with long experience from the orthopedics market" and letting three others go, according to a press release. Artimplant also consolidated its American admin and marketing support functions in a new office in Denver.
"With the new team in place we are firmly convinced that we will see positive developments on the U.S. market, which is vitally important for Artimplant," CEO Kjell Thörnbring said in prepared remarks. Read more
Myca Health names new patient management officer
Cloud-based EMR developer Myca Health Inc. promoted Steven Ferguson as patient management officer, effective immediately, from his prior role as vice president of product management. Read more
Aptiv Solutions names new brand manager, regulatory chief
Aptiv Solutions named Phil Birch to be the new senior vice president and corporate brand manager for its adaptive clinical trials operation. The contract research organization promoted Carolyn Belcher to replace Birch as senior director and global head of its regulatory unit. Read more